Impact of an Epstein-Barr Virus Serology-Based Screening Program on Nasopharyngeal Carcinoma Mortality: A Cluster-Randomized Controlled Trial.
Chen WJ, Yu X, Lu YQ, Pfeiffer RM, Ling W, Xie SH, Wu ZC, Li XQ, Fan YY, Wu BH, Wei KR, Rao HL, Huang QH, Guo X, Sun Y, Ma J, Liu Q, Hildesheim A, Hong MH, Zeng YX, Ji MF, Liu Z, Cao SM.
Chen WJ, et al. Among authors: hildesheim a.
J Clin Oncol. 2024 Oct 1:JCO2301296. doi: 10.1200/JCO.23.01296. Online ahead of print.
J Clin Oncol. 2024.
PMID: 39353160